Norio Seijiro Shirahama - Net Worth and Insider Trading

Norio Seijiro Shirahama Net Worth

The estimated net worth of Norio Seijiro Shirahama is at least $2 dollars as of 2024-04-25. Norio Seijiro Shirahama is the President - Asia Pacific of Plus Therapeutics Inc and owns about 1 shares of Plus Therapeutics Inc (PSTV) stock worth over $2. Details can be seen in Norio Seijiro Shirahama's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Norio Seijiro Shirahama has not made any transactions after 2010-06-04 and currently still holds the listed stock(s).

Transaction Summary of Norio Seijiro Shirahama

To

Norio Seijiro Shirahama Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Norio Seijiro Shirahama owns 1 companies in total, including Plus Therapeutics Inc (PSTV) .

Click here to see the complete history of Norio Seijiro Shirahama’s form 4 insider trades.

Insider Ownership Summary of Norio Seijiro Shirahama

Ticker Comapny Transaction Date Type of Owner
PSTV Plus Therapeutics Inc 2010-06-04 SVP Asia Pacific

Norio Seijiro Shirahama Latest Holdings Summary

Norio Seijiro Shirahama currently owns a total of 1 stock. Norio Seijiro Shirahama owns 1 shares of Plus Therapeutics Inc (PSTV) as of June 4, 2010, with a value of $2.

Latest Holdings of Norio Seijiro Shirahama

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PSTV Plus Therapeutics Inc 2010-06-04 1 1.60 2

Holding Weightings of Norio Seijiro Shirahama


Norio Seijiro Shirahama Form 4 Trading Tracker

According to the SEC Form 4 filings, Norio Seijiro Shirahama has made a total of 0 transactions in Plus Therapeutics Inc (PSTV) over the past 5 years. The most-recent trade in Plus Therapeutics Inc is the acquisition of 0 shares on June 4, 2010, which cost Norio Seijiro Shirahama around $6,855.

Insider Trading History of Norio Seijiro Shirahama

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Norio Seijiro Shirahama Trading Performance

GuruFocus tracks the stock performance after each of Norio Seijiro Shirahama's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Norio Seijiro Shirahama is 6.76%. GuruFocus also compares Norio Seijiro Shirahama's trading performance to market benchmark return within the same time period. The performance of stocks bought by Norio Seijiro Shirahama within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Norio Seijiro Shirahama's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Norio Seijiro Shirahama

Average Return

44.4%

Average return per transaction

Outperforming Transactions

100%

4 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.74 6.76 26.57 44.4 14.61 -9.32
Relative Return to S&P 500(%) 12.33 5.42 16.03 26.44 8.48 -11.72

Norio Seijiro Shirahama Ownership Network

Ownership Network List of Norio Seijiro Shirahama

No Data

Ownership Network Relation of Norio Seijiro Shirahama


Norio Seijiro Shirahama Owned Company Details

What does Plus Therapeutics Inc do?

Who are the key executives at Plus Therapeutics Inc?

Norio Seijiro Shirahama is the SVP Asia Pacific of Plus Therapeutics Inc. Other key executives at Plus Therapeutics Inc include President Marc H Hedrick , Chief Financial Officer Sims Andrew John Hugh Macintyre , and CHIEF MEDICAL OFFICER Norman D. Lafrance .

Plus Therapeutics Inc (PSTV) Insider Trades Summary

Over the past 18 months, Norio Seijiro Shirahama made no insider transaction in Plus Therapeutics Inc (PSTV). Other recent insider transactions involving Plus Therapeutics Inc (PSTV) include a net purchase of 23,094 shares made by Robert P Lenk , a net purchase of 10,493 shares made by Howard Clowes , and a net purchase of 20,000 shares made by Greg Petersen .

In summary, during the past 3 months, insiders sold 0 shares of Plus Therapeutics Inc (PSTV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,568 shares of Plus Therapeutics Inc (PSTV) were sold and 55,087 shares were bought by its insiders, resulting in a net purchase of 51,519 shares.

Plus Therapeutics Inc (PSTV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Plus Therapeutics Inc Insider Transactions

No Available Data

Norio Seijiro Shirahama Mailing Address

Above is the net worth, insider trading, and ownership report for Norio Seijiro Shirahama. You might contact Norio Seijiro Shirahama via mailing address: C/o Cytori Therapeutics, Inc., 3020 Callan Road, San Diego Ca 92121.

Discussions on Norio Seijiro Shirahama

No discussions yet.